Anywhere from 20% to 60% of the adults around the world may be infected with the new coronavirus SARS-CoV-2, the virus that causes the disease COVID-19. That’s the estimate from leading epidemiological experts on communicable disease dynamics. Even the best-case scenario using those numbers means nearly 40,000,000 adults will be infected in the United States alone.
<!–
2 of 18 –>
Some people may start to feel fatalistic in the face of those kinds of statistics. There are no vaccines and no specific treatments for people who get sick. What’s the point of fighting something that’s bound to happen anyway? Why not just let the epidemic run its course?
<!–
3 of 18 –>
But public health officials and medical professionals have been advocating for rapid and decisive efforts to reduce the transmission of SARS-CoV-2 as much and as early as possible.
<!–
4 of 18 –>
The goal is to “flatten the curve.” Rather than letting the virus quickly rampage through the population and burn itself out fast, the idea is to spread all those infections out over a longer period of time.
<!–
5 of 18 –>
Flattening the curve is another way of saying buying more time.
Most importantly, “flattening the curve” provides an opportunity to significantly reduce deaths from COVID-19.
<!–
7 of 18 –>
On the steep rise of the epidemic curve, especially when testing capacity is lacking, there is a tremendous burden on health care providers – many of whom will fall ill themselves and be forced to self-isolate, becoming unable to provide care for those in need. At the same time, there is immense pressure placed on health care facilities where demand for patient care will outpace capacity – things like the number of hospital beds, ventilators and so on – for a significant amount of time.
<!–
8 of 18 –>
So yes, even if every person on Earth eventually comes down with COVID-19, there are real benefits to making sure it doesn’t all happen in the next few weeks.
<!–
9 of 18 –>
How, then, can people “flatten the curve” via reducing transmission of the coronavirus? At present, with many regions of the United States and other countries seeing community members spreading COVID-19 locally, the world has entered a phase of mitigation to complement efforts to contain its spread.
<!–
10 of 18 –>
As a result, we’re left with an old but quite effective strategy: social distancing. It means staying out of close contact in crowded public places, avoiding mass gatherings and maintaining space – approximately six feet – between yourself and others when possible.
<!–
11 of 18 –>
Social distancing requires changes in how people work, live and interact with each other. It may require canceling or avoiding big events, limiting nonessential travel and rescheduling conferences. Traditional classroom instruction may have to move to online delivery – already happening in some colleges and universities, though less easy to do for K-12 schools.
<!–
12 of 18 –>
To be clear, social distancing comes with a substantial economic cost as people aren’t engaged in the same work and life activities that fuel the economy as they were just a month or two ago. As a result, public health and government officials are faced with balancing the public health push to “flatten the curve” with desires to minimize the impact on the economy.
<!–
13 of 18 –>
As the COVID-19 pandemic unfolds, public health experts across the world are collecting data and communicating information as fast as possible in an attempt to provide health care providers, research laboratories, public health agencies and policymakers with the knowledge they need to respond to the emerging threat. In the meantime, one of the most important things individuals can do for our collective public health is to listen to the experts and follow their advice.
<!–
14 of 18 –>
World Health Organization Director-General Tedros Adhanom recently commented that “We need to remember that with decisive, early action, we can slow down the virus and prevent infections.” We’re not going to stamp out COVID-19. But by not just throwing up our hands and giving up, people can help address the crisis early, preventing COVID-19 from overwhelming the health care system’s capacity to respond effectively.
… then let us make a small request. AlterNet’s journalists work tirelessly to counter the traditional corporate media narrative. We’re here seven days a week, 365 days a year. And we’re proud to say that we’ve been bringing you the real, unfiltered news for 20 years—longer than any other progressive news site on the Internet.
It’s through the generosity of our supporters that we’re able to share with you all the underreported news you need to know. Independent journalism is increasingly imperiled; ads alone can’t pay our bills. AlterNet counts on readers like you to support our coverage. Did you enjoy content from David Cay Johnston, Common Dreams, Raw Story and Robert Reich? Opinion from Salon and Jim Hightower? Analysis by The Conversation? Then join the hundreds of readers who have supported AlterNet this year.
The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.
It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.
Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”
Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.
Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.
A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.
On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.
Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”
But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”
“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.
Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.
Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.
Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.
“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.
“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”
This report by The Canadian Press was first published Sept. 13, 2024.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.
The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.
Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.
“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”
The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.
A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.
Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.
“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.
Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.
The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.
“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.
This report by The Canadian Press was first published Sept. 11, 2024.
ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.
Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.
Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.
Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.
The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.
“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.
Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.
Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.
Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.
A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.
This report by The Canadian Press was first published Sept. 10, 2024.
